Correlation Between NextCure and I Mab

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both NextCure and I Mab at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NextCure and I Mab into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NextCure and I Mab, you can compare the effects of market volatilities on NextCure and I Mab and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NextCure with a short position of I Mab. Check out your portfolio center. Please also check ongoing floating volatility patterns of NextCure and I Mab.

Diversification Opportunities for NextCure and I Mab

0.71
  Correlation Coefficient

Poor diversification

The 3 months correlation between NextCure and IMAB is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding NextCure and I Mab in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on I Mab and NextCure is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NextCure are associated (or correlated) with I Mab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of I Mab has no effect on the direction of NextCure i.e., NextCure and I Mab go up and down completely randomly.

Pair Corralation between NextCure and I Mab

Given the investment horizon of 90 days NextCure is expected to under-perform the I Mab. But the stock apears to be less risky and, when comparing its historical volatility, NextCure is 1.05 times less risky than I Mab. The stock trades about -0.16 of its potential returns per unit of risk. The I Mab is currently generating about -0.14 of returns per unit of risk over similar time horizon. If you would invest  148.00  in I Mab on October 7, 2024 and sell it today you would lose (54.00) from holding I Mab or give up 36.49% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

NextCure  vs.  I Mab

 Performance 
       Timeline  
NextCure 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days NextCure has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in February 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
I Mab 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days I Mab has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

NextCure and I Mab Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with NextCure and I Mab

The main advantage of trading using opposite NextCure and I Mab positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NextCure position performs unexpectedly, I Mab can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in I Mab will offset losses from the drop in I Mab's long position.
The idea behind NextCure and I Mab pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios